Published:
Celldex Therapeutics to Present at Merriman Curhan Ford's Investor Summit 2009
NEEDHAM, Mass. - (BUSINESS WIRE) - Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony
S. Marucci, President and Chief Executive Officer of Celldex
Therapeutics, Inc., will present at Merriman Curhan Ford's 6th
Annual Investor Summit at the Sofitel Hotel, New York City on Tuesday,
November 10, 2009 at 2:40 pm, EST.
A live webcast of the 15-minute audio presentation will be available
online at http://www.wsw.com/webcast/mcm12/cldx/
and on the "Presentations" page of the Investor Information section of
Celldex's website at http://www.celldextherapeutics.com.
An archive of the webcast will be available via Celldex's website for 90
days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is an integrated biopharmaceutical company that
applies its comprehensive Precision Targeted Immunotherapy Platform to
generate a pipeline of candidates to treat cancer and other
difficult-to-treat diseases. Celldex's immunotherapy platform includes a
complementary portfolio of monoclonal antibodies, antibody-targeted
vaccines and immunomodulators to create novel disease-specific drug
candidates. For more information, please visit http://www.celldextherapeutics.com.
About Merriman Curhan Ford
Merriman Curhan Ford (NASDAQ:
MERR) is a financial services firm focused on fast-growing companies
and the institutions that invest in them. The company offers
high-quality investment banking, equity research, institutional services
and corporate & venture services, and specializes in five growth
industry sectors: CleanTech, Consumer, Media & Internet,
Health Care, Natural Resources and Technology. For more information,
please go to www.mcfco.com.
Celldex Therapeutics, Inc.
Anthony S. Marucci, 781-433-0771
President
and CEO
or
Avery W. Catlin, 781-433-0771
Chief Financial
Officer
IR@celldextherapeutics.com
or
Celldex
Investor Relations:
MacDougall Biomedical Communications
Sarah
Cavanaugh, 781-235-3060
scavanaugh@macbiocom.com
or
Celldex
Media:
BMC Communications Group
Matthew Driscoll,
212-477-9007 x20
mdriscoll@bmccommunications.com
Copyright © 2009, Business Wire, Inc., All rights reserved.
Copyright © 2009, NewsBlaze,
Daily NewsTags: Business wire, Banking and Finance, Healthcare, massachusetts, Health, Biotechnology, Pharmaceuticals, Medical, Consulting, Accounting and other Professional Services
Search News
Daily News
